Aldeyra Therapeutics Aktie

  • Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

    May 20, 2020· Sorrento Therapeutics, Inc. NASDAQ: SRNE $6.62 up $0.27 (4.25%) Related Articles. Why Moderna Was a Big Winner on Friday; 3 Things About Moderna That The Smartest Investors Know ...

    Read More
  • Aldeyra Therapeutics Unternehmensnachrichten Aktie ...

    May 14, 2021· Umfassend und topaktuell: Nachrichtenüberblick von der Aldeyra Therapeutics - WKN A111X8, ISIN US01438T1060 - bei finanztreff.de.

    Read More
  • ALDEYRA THERAPEUTICS, INC. : ALDX Stock Price ...

    Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes.

    Read More
  • Aldeyra Therapeutics Aktienporträt Aktie - A111X8 ...

    May 14, 2021· Ausführliches Aktienporträt der Aldeyra Therapeutics - WKN A111X8, ISIN US01438T1060 - bei finanztreff.de topaktuell!

    Read More
  • Aldeyra Therapeutics NEWS | Nachrichten hier lesen!

    lll Nachrichten zu Aldeyra Therapeutics | Analysen aktuelle News jetzt einfach und schnell bei ariva.de ansehen.

    Read More
  • ALDEYRA THERAPEUTICS Aktie: Aktienkurs, Chart & News ...

    May 14, 2021· ALDEYRA THERAPEUTICS (A111X8 | US01438T1060) mit aktuellem Aktienkurs, Charts, News und Analysen.

    Read More
  • Aldeyra Therapeutics Aktie - Trading-Desk

    Mar 22, 2021· Aldeyra Therapeutics Inc. Aktie. Echtzeit-Preisindikation vom 22.03.2021 um 10:41 Uhr!

    Read More
  • ALDEYRA THERAPEUTICS AKTIE | Aktienkurs | A111X8 ...

    Aldeyra Therapeutics ist ein Unternehmen . Die Aldeyra Therapeutics-Aktien notieren unter der WKN bzw. der ISIN US01438T1060 . mit einem hohe Streubesitz von 91%. Die Aldexa Therapeutics Inc Aktie wird unter der ISIN US01438T1060 an den Börsen Frankfurt, Stuttgart, Berlin, NASDAQ, Bats, NDB und Lang & Schwarz gehandelt.

    Read More
  • ALDX Stock Forecast, Price & News (Aldeyra Therapeutics)

    May 17, 2021· Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company's lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic ...

    Read More
  • ALDX | Aldeyra Therapeutics Inc. Stock Price & News - WSJ

    View the latest Aldeyra Therapeutics Inc. (ALDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

    Read More
  • Aldeyra Therapeutics Inc (ALDX) Quote - XNAS | Morningstar

    May 18, 2021· Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's ...

    Read More
  • Aldeyra Therapeutics : to Present New Reproxalap Data from ...

    Oct 22, 2020· Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company’s lead compounds, reproxalap and ADX-629, target reactive aldehyde species (RASP), which are elevated in ocular and systemic ...

    Read More
  • Aldeyra Therapeutics Aktie (A111X8,US01438T1060) | Kurs ...

    Aldeyra Therapeutics Aktie: Aktueller Aktienkurs Charts Nachrichten Realtime WKN: A111X8 | ISIN: US01438T1060

    Read More
  • Aldeyra Therapeutics (ALDX) - Teknisk analyse - US Stocks ...

    Aldeyra Therapeutics, Inc. ligger i en stigende tr This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

    Read More
  • CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote ...

    Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.

    Read More
  • 40% in 3 Tagen: AKTIONÄR-Tipp feiert Traumstart - DER AKTIONÄR

    Jan 18, 2021· Die US-Biotechfirma Aldeyra Therapeutics hat sich innerhalb kurzer Zeit mehr als verdoppelt. 18.01.2021 ... Das auf Augenkrankheiten spezialisierte Unternehmen will rund 6,84 Millionen neue Aktien ...

    Read More
  • Atossa Therapeutics - A Clinical-Stage Biopharmaceutical ...

    Atossa Therapeutics is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19. About Atossa Contact Us.

    Read More
  • ALDEYRA THERAPEUTICS AKTIE | Aktienkurs | A111X8 ...

    Aldeyra Therapeutics Aktie - Hier finden Sie: Aldeyra Therapeutics Aktienkurs aktuell, Kurs, Chart und alle Kennzahlen für die Aldeyra Therapeutics Aktie.

    Read More
  • Aldeyra News: Aktuelle Nachrichten im Ticker (Deutsch)

    Apr 28, 2021· Aldeyra Therapeutics: Bewertung mittels Branchenvergleich Die Aktie hat im vergangenen Jahr eine Rendite von 111,18 Prozent erzielt. Im Vergleich zu Aktien aus dem gleichen Sektor liegt Aldeyra Therapeutics damit 95,79…

    Read More
  • ALDEYRA THERAPEUTICS, INC. : 137 Stock Price | MarketScreener

    Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes.

    Read More
  • Aldeyra Therapeutics, Inc. (ALDX) Stock Price, News, Quote ...

    Aldeyra Therapeutics, Inc. Announces Pricing of $125 Million Public Offering of Common Stock. Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a …

    Read More
  • ALDX Catches Eye, RVNC Faces Busy Year Ahead ... - Aktien

    Jan 08, 2021· Aldeyra Therapeutics, Inc. (ALDX) CEO Todd Brady on Q1 2021 Results - Earnings Call Transcript: 06.05. Aldeyra Therapeutics, Inc. - 8-K, Current Report: 28.04. Why Aldeyra Therapeutics Stock Is ...

    Read More
  • ALDEYRA THERAPEUTICS Aktie | Kennzahlen | Fundamental ...

    ALDEYRA THERAPEUTICS (A111X8 | US01438T1060): Überblick aller relevanten Fundamentalkennzahlen zum Unternehmen, wie z.B. Gewinn, Dividende, Cash-Flow und Umsatz.

    Read More
  • ALDEYRA THERAPEUTICS, INC. : Kurs Aktie Börse | A111X8 ...

    ALDEYRA THERAPEUTICS, INC. : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen der Aktie ALDEYRA THERAPEUTICS, INC. | A111X8 ...

    Read More
  • Aldeyra Therapeutics, Inc. Announces Pricing of Public ...

    Jan 14, 2021· Aldeyra Therapeutics Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de. Diesen Artikel teilen. Wertpapier. Aldeyra Therapeutics Aktie . 0 Kommentare.

    Read More
  • Aldeyra Therapeutics Aktie | ISIN US01438T1060 | WKN ...

    Apr 26, 2021· Aldeyra Therapeutics Aktie (ISIN US01438T1060 / WKN 01438T106). Aktueller Kurs, historische Charts, Analystenchecks und aktuelle Nachrichten zur Aldeyra Therapeutics Aktie

    Read More
  • Aldeyra Aktie: Nochmal +22% Potenzial? | CMC Markets

    Jan 15, 2021· D ie Aktien von Aldeyra Therapeutics (+19,8% auf $12,18) sind im Höhenflug. Auslöser für den Anstieg des Kurses der Aldeyra Aktie von 6,69 USD am 6. Januar auf zwischenzeitlich 12,68 USD am 12. Januar - immerhin ein Plus von 90% - war die Bekanntgabe von Fortschritten bei der Entwicklung des wichtigsten Medikaments des Unternehmens.

    Read More
  • Analysen zur Aldeyra Therapeutics Aktie | Aldeyra ...

    Jan 26, 2018· Aldeyra Therapeutics Analysen - hier finden Sie eine Übersicht aller relevanter Aktienanalysen zur Aldeyra Therapeutics Aktie von Banken, Investmenthäusern und Medien.

    Read More
  • Aldeyra Therapeutics (ALDX) • Aktie • A111X8 / US01438T1060

    Aldeyra Therapeutics Aktie (ALDX) Branche: : (WKN: A111X8 ISIN: US01438T1060 ) Kurs mit Realtime Chart Alle Entwicklungen, Kommentare und News auf BörsenNEWS.de live verfolgen.

    Read More
  • How Aldeyra (ALDX) Stock Stands Out in a Strong Industry ...

    May 15, 2020· Aldeyra Therapeutics, Inc. price-consensus-chart | Aldeyra Therapeutics, Inc. Quote. In fact, over the past month, current quarter estimates have narrowed from a …

    Read More

Contact us

  • Address: Building 8, 098, Chuansha Road, Pudong New Area, Shanghai
  • E-mail: [email protected]

Customer Cases